accountBy Ashby Jones The big law-and-biz headline from Wednesday involved drug maker GlaxoSmithKline, which agreed to pay $750 million and enter a guilty plea to settle charges that it put bad drugs into the stream of commerce. But a fascinating...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to The Story Behind the $96M Whistleblowing Recovery
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account